1-4 of 4
Paul Albert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autoimmune Cytopenia Associated with Indolent B-Cell Clones: A Large Multicentric Cohort Study

Yoann Zadro, Amélie Lusque, Heloise Rey, Julie Graveleau, Fanny Lemarie, Lenaig Le Clech, Corentin Orvain, Paul Albert Domnariu, Clement Gourguechon, Etienne Crickx, Kamel Laribi, Delphine Gobert, Leonce Adjoumani, Emilie Berthoux, Alban Deroux, Marie Durel, Mickael Ebbo, Jonathan Farhi, Sebastien Humbert, Vincent Jachiet, Pierre Cougoul, Jeremie Dion, Brice Castel, Clement Begey, Jean-Baptiste Rieu, Samuel Deshayes, Mathilde Devaux, Isabelle Durieu, Martin Gauthier, Jean-Francois Viallard, Nihal Martis, Jérôme Paillassa, Guillaume Denis, Sondess Hadj Khelifa, Christian Lavigne, Francois Lifermann, Guillaume Moulis, Arsene Mekinian, Loic Ysebaert, Marc Michel, Bertrand Godeau, Thibault Comont
Journal: Blood
Blood (2023) 142 (Supplement 1): 800.
https://doi.org/10.1182/blood-2023-178535
Published: 2023
Journal Articles

RIG-I Activation Is Critical for Responsiveness to Checkpoint Blockade

Simon Heidegger, MD, Alexander Wintges, Florian Stritzke, Katja Steiger, Paul-Albert Koenig, Thomas Engleitner, Julius Clemens Fischer, Vladimir Makarov, Christof Winter, Roland Rad, Marcel R.M. van den Brink, MD PhD, Jürgen Ruland, Florian Bassermann, MD PhD, Timothy Chan, Tobias Haas, MD, Hendrik Poeck, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 624.
https://doi.org/10.1182/blood-2019-128724
Published: 2019
Journal Articles

A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation

Sharvan Sehrawat, Paul-Albert Koenig, Oktay Kirak, Christian Schlieker, Manuel Fankhauser, Hidde L. Ploegh
Journal: Blood
Blood (2013) 121 (7): 1145–1156.
https://doi.org/10.1182/blood-2012-08-447409
Published: 2013
Includes: Supplemental data
Journal Articles

EBV-Related Lymphoproliferative Disease Complicating Therapy with Siplizumab, a Novel Anti-CD2 Mediated T- and NK-Cell Depleting Agent, in Patients with T-Cell Malignancies.

Deirdre O’Mahony, MD, John C. Morris, MD, Maryalice Stetler-Stevenson, MD, Helen Matthews, RN, Stefania Pittaluga, MD, Paul Albert, PhD, Karen Kaucic, MD, Luz Hammershaimb, MD, Thomas A. Waldmann, MD, John E. Janik, MD
Journal: Blood
Blood (2007) 110 (11): 3565.
https://doi.org/10.1182/blood.V110.11.3565.3565
Published: 2007